Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002651932 | SCV003526524 | likely pathogenic | Inborn genetic diseases | 2024-03-11 | criteria provided, single submitter | clinical testing | The c.929T>C (p.M310T) alteration is located in coding exon 9 of the PSMC3 gene. This alteration results from a T to C substitution at nucleotide position 929, causing the methionine (M) at amino acid position 310 to be replaced by a threonine (T). Based on data from the Genome Aggregation Database (gnomAD), the PSMC3 c.929T>C alteration was not observed, with coverage at this position. This amino acid position is highly conserved in available vertebrate species. This missense alteration is located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. |